Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Annals of the Rheumatic Diseases
|
January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Annals of the Rheumatic Diseases
|
October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Annals of the Rheumatic Diseases
|
September 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
Felix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2022
Multiparametric Prediction Models for Coronavirus Disease 2019 Vaccine Selection: Results of a Comparative Population-Based Cohort Study
Daniela Sieghart, Claudia A Hana, Helmuth Haslacher, et al.
Annals of the Rheumatic Diseases
|
January 6, 2018
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis
Helga Radner, Katerina Chatzidionysiou, Elena Nikiphorou, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 19, 2024
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy
Daniela Sieghart, Claudia A Hana, Caroline Dürrschmid, et al.
Rheumatology (Oxford, England)
|
March 27, 2012
Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative
Samuel L Whittle, Alexandra N Colebatch, Rachelle Buchbinder, et al.
Nature Communications
|
September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
Daniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Annals of the Rheumatic Diseases
|
August 21, 2019
Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries
Polina Putrik, Sofia Ramiro, Francis Guillemin, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Annals of the Rheumatic Diseases
|
January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
Michael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Annals of the Rheumatic Diseases
|
October 8, 2013
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
Maxime Dougados, Martin Soubrier, Anna Antunez, et al.
Annals of the Rheumatic Diseases
|
September 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls
Felix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2022
Multiparametric Prediction Models for Coronavirus Disease 2019 Vaccine Selection: Results of a Comparative Population-Based Cohort Study
Daniela Sieghart, Claudia A Hana, Helmuth Haslacher, et al.
Annals of the Rheumatic Diseases
|
January 6, 2018
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis
Helga Radner, Katerina Chatzidionysiou, Elena Nikiphorou, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 19, 2024
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy
Daniela Sieghart, Claudia A Hana, Caroline Dürrschmid, et al.
Rheumatology (Oxford, England)
|
March 27, 2012
Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative
Samuel L Whittle, Alexandra N Colebatch, Rachelle Buchbinder, et al.
Nature Communications
|
September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
Daniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Annals of the Rheumatic Diseases
|
August 21, 2019
Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries
Polina Putrik, Sofia Ramiro, Francis Guillemin, et al.
Page
of 7